Everspin Technologies, Inc (MRAM) is a publicly traded Technology sector company. As of May 21, 2026, MRAM trades at $29.76 with a market cap of $781.98M and a P/E ratio of -951.17. MRAM moved -8.80% today. Year to date, MRAM is +171.74%; over the trailing twelve months it is +374.43%. Its 52-week range spans $4.34 to $51.50. Analyst consensus is buy with an average price target of $18.00. Rallies surfaces MRAM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading MRAM stock inside the company?
Recent MRAM insider activity includes Aggarwal Sanjeev sold 83.05K, Aggarwal Sanjeev sold 19.14K, Aggarwal Sanjeev sold 8.78K, HAWK GLEN sold 17.38K, and HAWK GLEN sold 21.37K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
MRAM Key Metrics
Key financial metrics for MRAM
Metric
Value
Price
$29.76
Market Cap
$781.98M
P/E Ratio
-951.17
EPS
$-0.03
Dividend Yield
0.00%
52-Week High
$51.50
52-Week Low
$4.34
Volume
49.89K
Avg Volume
0
Revenue (TTM)
$55.20M
Net Income
$-586.00K
Gross Margin
51.16%
Recent MRAM Insider Trades
Aggarwal Sanjeev sold 83.05K (~$2.70M) on May 18, 2026.
Aggarwal Sanjeev sold 19.14K (~$635.77K) on May 18, 2026.
Aggarwal Sanjeev sold 8.78K (~$351.36K) on May 15, 2026.
HAWK GLEN sold 17.38K (~$644.65K) on May 15, 2026.
HAWK GLEN sold 21.37K (~$813.95K) on May 15, 2026.
Recent MRAM insider activity includes Aggarwal Sanjeev sold 83.05K, Aggarwal Sanjeev sold 19.14K, Aggarwal Sanjeev sold 8.78K, HAWK GLEN sold 17.38K, and HAWK GLEN sold 21.37K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for MRAM?
Yes. Rallies tracks MRAM insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is MRAM research on Rallies investment advice?
No. Rallies provides research, data, and educational context for MRAM. It does not provide personalized investment advice.